Ligand validation:4EN3

AGH: N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE

AGH is a Ligand Of Interest in 4EN3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4EN3_AGH_C_304	39%	71%	0.235	0.943	0.33	0.79	-	1	7	0	100%	1
3HUJ_AGH_A_3000	63%	68%	0.168	0.964	0.48	0.75	1	1	2	0	100%	1
1ZT4_AGH_A_282	42%	70%	0.2	0.92	0.5	0.64	1	-	13	0	100%	1
2PO6_AGH_E_2	40%	63%	0.255	0.968	0.52	0.87	1	2	1	0	100%	1
6BNK_AGH_A_405	56%	56%	0.187	0.96	0.89	0.83	3	-	1	0	100%	1
3TO4_AGH_A_303	32%	72%	0.282	0.959	0.38	0.71	-	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.